Loading the SOTA2 catalog…
MAUD 1.0
Generative AI platform for the de novo design of peptide macrocycles.
What is MAUD 1.0?
Generative AI platform for the de novo design of peptide macrocycles. It combines generative AI with physics-based models and quantum simulations to design drug-like peptides from scratch, validated across the preclinical discovery pipeline.
Product typeDrug Discovery & Biotech
Pricing ·
Deployment
APINot available
What teams use MAUD 1.0 for
De novo design of peptide macrocycles
Targeting Protein-Protein Interfaces (PPIs)
Preclinical drug discovery acceleration
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
